[Form 4] TG THERAPEUTICS, INC. Insider Trading Activity

Rhea-AI Filing Summary

Hoberman Kenneth reported acquisition or exercise transactions in this Form 4 filing.

TG Therapeutics director Kenneth Hoberman received an equity-based award tied to the company’s stock. He was granted 8,325 Stock Tracking Units on June 11, 2026, each linked to one share of common stock.

Each unit represents a contingent right, at the board committee’s discretion, to deliver either one share of common stock or a cash payment equal to the fair market value of one share, no later than 30 days after the first anniversary of the grant date. The units will vest on the first anniversary of the grant, provided he remains in continuous service with the company through that date.

Insights

Equity Compensation Analyst

Routine director equity grant with contingent stock-or-cash settlement.

The filing shows director Kenneth Hoberman receiving 8,325 Stock Tracking Units as a compensation award, with no exercise price and each unit tied to one share of common stock or its cash equivalent. This is a standard incentive structure rather than a market transaction.

The award vests on the first anniversary of the grant if he remains in continuous service, aligning compensation with at least one year of board service. Settlement method—stock or cash—is determined by the board committee, so any future share issuance or cash outlay depends on that later decision.

The grant does not involve open-market buying or selling and represents a relatively small, service-based incentive. Future disclosures would clarify how the company ultimately settles these units after the one-year vesting and settlement window.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Hoberman Kenneth

Role null

Type	Security	Shares	Price	Value
Grant/Award	Stock Tracking Unit	8,325	$0.00	--

Holdings After Transaction: Stock Tracking Unit — 8,325 shares (Direct, null)

Footnotes (1)

1. Each stock tracking unit ("STU") represents a contingent right to receive either (determined at the sole discretion of the committee of the Board of Directors of the Issuer that administers the Issuer's 2022 Incentive Plan) (i) one share of the Issuer's common stock or (ii) a cash payment equal to the fair market value of one share of the Issuer's common stock, no later than thirty (30) days after the first anniversary of the date of grant. Provided the Reporting Person remains in continuous service with the Issuer through the vesting date, the STUs shall vest upon the first anniversary of the date of grant.

Key Figures

Stock Tracking Units granted: 8,325 units Underlying common shares: 8,325 shares Exercise price: $0.00 per unit +3 more

6 metrics

Stock Tracking Units granted 8,325 units Grant to director Kenneth Hoberman on June 11, 2026

Underlying common shares 8,325 shares Each unit linked to one share of common stock

Exercise price $0.00 per unit Grant/award acquisition, no exercise price specified

Shares following transaction 8,325 units Total Stock Tracking Units held after the award

Vesting period 1 year Vests on first anniversary if continuous service is maintained

Settlement window 30 days Payment in stock or cash no later than 30 days after first anniversary

Key Terms

Stock Tracking Unit, contingent right, fair market value, 2022 Incentive Plan, +2 more

6 terms

Stock Tracking Unit financial

"Each stock tracking unit ("STU") represents a contingent right to receive either..."

contingent right financial

"represents a contingent right to receive either (i) one share ... or (ii) a cash payment..."

fair market value financial

"a cash payment equal to the fair market value of one share of the Issuer's common stock"

The price a willing buyer and a willing seller would agree on for an asset or security when neither is under pressure and both have access to the same information. Think of it as the market’s neutral estimate of what something is worth, like the price two neighbors would settle on for a car after comparing similar listings. Investors care because fair market value guides buying and selling decisions, tax reporting, portfolio valuation, and how accurately company assets are reflected in financial statements.

2022 Incentive Plan financial

"the committee ... that administers the Issuer's 2022 Incentive Plan"

A 2022 incentive plan is a formal program adopted in 2022 that outlines how a company will reward employees, executives, or directors with cash, stock, or other benefits tied to performance or continued service. Investors care because these plans can change how much ownership exists (dilution), affect reported profits through compensation costs, and influence whether managers are motivated to increase long‑term value—think of it as the rules for a company’s bonus and stock‑award system.

continuous service financial

"Provided the Reporting Person remains in continuous service with the Issuer through the vesting date"

vesting date financial

"the STUs shall vest upon the first anniversary of the date of grant"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hoberman Kenneth

(Last) (First) (Middle)

3020 CARRINGTON MILL BLVD, SUITE 475

(Street)

MORRISVILLE NORTH CAROLINA 27560

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
TG THERAPEUTICS, INC. [ TGTX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Tracking Unit	(1)	06/11/2026		A		8,325		(2)	(2)	Common Stock	8,325	$0	8,325	D

Explanation of Responses:

1. Each stock tracking unit ("STU") represents a contingent right to receive either (determined at the sole discretion of the committee of the Board of Directors of the Issuer that administers the Issuer's 2022 Incentive Plan) (i) one share of the Issuer's common stock or (ii) a cash payment equal to the fair market value of one share of the Issuer's common stock, no later than thirty (30) days after the first anniversary of the date of grant.

2. Provided the Reporting Person remains in continuous service with the Issuer through the vesting date, the STUs shall vest upon the first anniversary of the date of grant.

	/s/ Kenneth Hoberman	06/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)